- Condition: Influenza, Human
Intervention: Biological: CSL Influenza Vaccine
Sponsors: CSL Limited; CSL Limited
Not yet recruiting - verified May 2012 - Condition: Hereditary Angioedema Types I and II
Interventions: Biological: C1-esterase inhibitor - single intravenous dose; Biological: C1-esterase inhibitor - subcutaneous low dose; Biological: C1-esterase inhibitor - subcutaneous medium dose; Biological: C1-esterase inhibitor - subcutaneous high dose
Sponsors: CSL Behring; CSL Behring; Parexel
Recruiting - verified May 2012 - A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated MyelopathyCondition: HIV-associated Myelopathy
Interventions: Drug: Intravenous Immunoglobulin; Drug: Placebo
Sponsors: Mount Sinai School of Medicine; David M. Simpson; CSL Behring
Recruiting - verified March 2012 - Condition: Healthy
Interventions: Biological: rVIIa-FP; Biological: Placebo (0.9% normal saline)
Sponsors: CSL Behring; CSL Behring
Recruiting - verified May 2012 - Conditions: Chronic Inflammatory Demyelinating Polyneuropathy; Polyradiculoneuropathy
Interventions: Biological: IgPro20; Biological: Placebo
Sponsors: CSL Behring; CSL Behring; Parexel
Recruiting - verified March 2012 - Condition: Cytomegalovirus Disease
Interventions: Drug: Valganciclovir; Biological: CMV hyperimmune globulin; Drug: Valganciclovir
Sponsors: Medical University of South Carolina; Medical University of South Carolina; CSL Behring
Recruiting - verified December 2011 - Condition: Stable Atherothrombotic Disease
Interventions: Biological: CSL112 (reconstituted high density lipoprotein); Biological: Placebo
Sponsors: CSL Limited; CSL Limited
Recruiting - verified April 2012 - Condition: Hemophilia B
Intervention: Biological: rIX-FP
Sponsors: CSL Behring; CSL Behring
Recruiting - verified May 2012 - Conditions: Blood Coagulation Disorders; Hemorrhage
Intervention: Drug: Human fibrinogen concentrate
Sponsors: University Children's Hospital, Zurich; University Children's Hospital, Zurich
Recruiting - verified January 2012 - Condition: Hemophilia A
Intervention: Biological: Recombinant Factor VIII (rFVIII)
Sponsors: CSL Behring; CSL Behring
Recruiting - verified April 2012 - Conditions: Surgical Blood Loss; Postoperative Blood Loss
Interventions: Biological: Fibrinogen Concentrate (Human) (FCH); Biological: Placebo
Sponsors: CSL Behring; CSL Behring
Recruiting - verified May 2012 - Condition: Hereditary Angioedema Types I and II
Intervention: Biological: Berinert, lyophilisate for IV application containing 500 units (U) C1-INH to be reconstituted with 10 mL water for injection
Sponsors: CSL Behring; CSL Behring
Recruiting - verified May 2012 - Condition: Heart Disease
Interventions: Drug: Fibrinogen; Drug: Saline solution; Drug: Prothrombin complex
Sponsors: IRCCS Policlinico S. Donato; IRCCS Policlinico S. Donato; CSL Behring
Recruiting - verified May 2012 - Condition: Primary Immune Deficiency
Intervention: Biological: Immune globulin subcutaneous (Human)
Sponsors: CSL Behring; CSL Behring
Active, not recruiting - verified April 2012 - Condition: Primary Immune Deficiency Disorder
Intervention: Biological: Immune globulin subcutaneous (Human)
Sponsors: CSL Behring; CSL Behring
Active, not recruiting - verified April 2012 - Condition: Hemophilia A
Intervention: Biological: Biostate
Sponsors: CSL Behring; CSL Behring
Not yet recruiting - verified April 2012 - Condition: Influenza
Interventions: Biological: Inflexal V influenza vaccine (CSL HA Antigen) 2010/2011; Biological: Inflexal V influenza vaccine (AdImmune HA antigen) 2010/2011
Sponsors: Crucell Holland BV; Crucell Holland BV
Completed - verified March 2012 - Condition: Immune Thrombocytopenic Purpura
Intervention: Biological: IgPro10
Sponsors: CSL Behring; CSL Behring
Recruiting - verified April 2012 - Condition: HIV Disease
Interventions: Biological: alpha-1-Proteinase Inhibitor; Biological: alpha-1-Proteinase Inhibitor; Biological: alpha-1-Proteinase Inhibitor; Biological: alpha-1-Proteinase Inhibitor
Sponsors: Cabrini Medical Centre; Cabrini Medical Centre; CSL Behring
Completed - verified December 2006
 |
CSL - Database of Clinical Trials by Pharmaceutical Companies |
